Literature DB >> 22492179

Last observation carried forward approach threatens the validity of intent-to-treat analysis in fibromyalgia trials: comment on the article by Arnold et al.

Markus Bredemeier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22492179     DOI： 10.1002/art.34493

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  1 in total

Review 1.  Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis.

Authors:  Markus Bredemeier; Guilherme G Campos; Fernando K de Oliveira
Journal:  Clin Rheumatol       Date:  2015-06-12       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.